Ardelyx, Inc.
Ardelyx, Inc.'s email is info@ardelyx.com
and
Ardelyx, Inc.'s phone number is 510) 745-1700
.
Ardelyx develops novel, first-in-class oral therapeutics to correct mineral metabolism and metabolic disorders. The Company's molecules, whose systemic exposure is severely restricted, target transporters and receptors, modulating the uptake of nutrients or inducing secretion of key hormones to produce a therapeutic benefit in patients. The Company's non-systemic products act from within the intestines to avoid potential side effects that could occur with systemic exposure. The Company's lead product, RDX5791, a minimally-absorbed, orally administered NHE3 sodium transpo...
read more
Ardelyx develops novel, first-in-class oral therapeutics to correct mineral metabolism and metabolic disorders. The Company's molecules, whose systemic exposure is severely restricted, target transporters and receptors, modulating the uptake of nutrients or inducing secretion of key hormones to produce a therapeutic benefit in patients. The Company's non-systemic products act from within the intestines to avoid potential side effects that could occur with systemic exposure. The Company's lead product, RDX5791, a minimally-absorbed, orally administered NHE3 sodium transport inhibitor, is being developed both for constipation-predominant irritable bowel syndrome (IBS-C) and for prevention of excess dietary sodium absorption, a new treatment modality for high blood pressure. RDX5791 is in phase 2 for IBS-C and a dose-ranging/regimen study for inhibition of excess dietary sodium absorption. Ardelyx is also developing RDX002, a minimally-absorbed, orally administered NaP2b phosphate transport inhibitor for the inhibition of phosphate absorption in patients with chronic kidney disease, and RDX009, a minimally-absorbed, orally administered TGR5 agonist for the treatment of type 2 diabetes through direct induction of intestinal incretins such as GLP-1 and PYY. Both RDX002 and RDX009 are in preclinical development. To date, Ardelyx has raised $56M in venture and angel funding since it was founded in 2007. Ardelyx is located in Fremont, California.
show less
Website | ardelyx.com | |
Industry | Biotechnology | |
Location | Fremont, California, United States | |
Employees | 109 | |
Founded | 2007 |
HQ | 34175 Ardenwood Blvd. | |
Phone | 510) 745-1700 | |
info@ardelyx.com | ||
Funding | 326,375,321 USD | |
Competitors | Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences, |
Website | ardelyx.com | |
Industry | Biotechnology | |
Location | Fremont, California, United States | |
Employees | 109 | |
Founded | 2007 | |
linkedin.com/company/ardelyx-inc- | ||
HQ | 34175 Ardenwood Blvd. | |
Phone | 510) 745-1700 | |
info@ardelyx.com | ||
Funding | 326,375,321 USD |
Email Patterns for Ardelyx, Inc.
Top Competitors for Ardelyx, Inc.
Ardelyx, Inc. Questions
Where are Ardelyx, Inc.'s headquarters?
Ardelyx, Inc.'s headquarters are in 34175 Ardenwood Blvd.
What is Ardelyx, Inc.'s phone number?
Ardelyx, Inc.'s phone number is 510) 745-1700
What is Ardelyx, Inc.'s official website?
Ardelyx, Inc.'s website is ardelyx.com
How many employees are working in Ardelyx, Inc. right now?
Ardelyx, Inc. has
109 employees.
View the Email and Phone Numbers for all 109 working at Ardelyx, Inc..
What is Ardelyx, Inc.'s industry?
Ardelyx, Inc.'s industry is
Biotechnology
Who are Ardelyx, Inc.'s top competitors?
Ardelyx, Inc.'s top competitors are
Roche
,
Agilent Technologies
,
Amgen
,
Genentech
,
Eurofins
,
Gilead Sciences
What is Ardelyx, Inc.'s email address?
Ardelyx, Inc.'s email address is info@ardelyx.com
What are Ardelyx, Inc.'s categories?
Ardelyx, Inc.'s categories are Biotechnology, Health Care, Medical
What is Ardelyx, Inc.'s location?
Ardelyx, Inc.'s location is
Fremont, California, United States
When was Ardelyx, Inc.'s founded?
Ardelyx, Inc.'s founding year is 2007
What is Ardelyx, Inc.'s funding?
Ardelyx, Inc.'s funding is 326,375,321 USD
What is Ardelyx, Inc.'s current status?
Ardelyx, Inc.'s current status is ipo
Top Ardelyx, Inc. Employees
Vice President, Payer Access
daniel.olmstead@genzyme.com
+1617-466-3500
Area Business Director
tracy.courter@boehringer-ingelheim.com
+1703-927-0392
Payroll Mananger
mzesfahu@epri.com
+1408-243-1721
Senior Director, Global Marketing And New Product Planning
annemarie.ryberg@genzyme.com
+1617-252-7570
Case Manager
dpogge@gmail.com
+1617-252-7570
Executive Assistant To President And Chief Executive Officer At Ardelyx, Inc
vdavid@shorenstein.com
+1585-730-0764
Senior Product Manager
littlebuddies24@gmail.com
+1978-994-3808